Sign in

Kate Cwynarski

@cwynkate2.bsky.social
644 followers 54 following 1 posts

Lymphoma & partic CNSL, TCL & immunodeficiency UCLH/UCL (no medical advice) views my own

PostsRepliesMedia
Reposted by Kate Cwynarski
Women in Lymphoma @womeninlymphoma.bsky.social · 28/05/2025
Going to ASCO this weekend? Come say hi to our team Ann LaCasce, Nina Shah , David Wright & see our global Gender Equity Survey results. Poster board 396, June 1st, 9-12pm More details about the survey to come at our EHA presentation June 14th, 5:15pm in Amber Hall 3+4
012
Kate Cwynarski @cwynkate2.bsky.social · 09/01/2025
T cell malignancies after CAR T cell therapy in the DESCAR-T registry Of 3,066 patients: (2,536 B cell lymphoma, 162 ALL, 368 MM) ONLY 1 (0.03%) pt dev a T cell malignancy after CAR T infusion @RemyDulery Roch Houot @NatureMedicine pubmed.ncbi.nlm.nih.gov/39779930/
pubmed.ncbi.nlm.nih.gov
T cell malignancies after CAR T cell therapy in the DESCAR-T registry - PubMed
The risk of T cell malignancies after chimeric antigen receptor (CAR) T cell therapy is a concern, although the true incidence remains unclear. Here we analyzed the DESCAR-T registry database, encompa...
18270
Reposted by Kate Cwynarski
Nicole Wong Doo @nicolewongdoo.bsky.social · 08/12/2024
Patient-entered data in Waldenstrom’s: WhiMSICAL delivers real world outcomes and empowers patients to be partners in research. Congrats Ryan Low, @judithtrotman.bsky.social IMWF, WMozzies #ASH24 #ASHKudos
0111
Reposted by Kate Cwynarski
Paola Ghione MD MS @paola-ghione.bsky.social · 09/12/2024
Such a beautiful energy @womeninlymphoma.bsky.social @judithtrotman.bsky.social and plans for the next WiL projects #lymsm #ASH24
095
Reposted by Kate Cwynarski
Graham Collins @graham74gc.bsky.social · 10/12/2024
It’s the end of #ASH24. Enjoying some time in La Jolla with wonderful friends before heading back on the Heathrow red eye!
091
Reposted by Kate Cwynarski
Prof Eliza Hawkes @elizahawkes.bsky.social · 23/11/2024
Our multidisciplinary team identified that in #lymsm patients having anthracycline, coronary artery calcium measured on baseline PET/CT predicts cardiac events ashpublications.org/bloodadvance... #hemesky @onjcri.bsky.social
ashpublications.org
PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated lymphoma patients
Key Points. Coronary calcium score calculated on pre-treatment PET/CT identifies lymphoma patients at risk of cardiac events after anthracycline therapyCor
0102
Reposted by Kate Cwynarski
Eddie Cliff @eddiecliff.bsky.social · 16/11/2024
Just out at JAMA Oncology, led by Parsa Erfani We review why many efforts to improve access to oncology medicines around the world have failed so far, especially compared to infectious diseases, & offer potential strategies to improve global pharmacoequity jamanetwork.com/journals/jam...
042
Reposted by Kate Cwynarski
Women in Lymphoma @womeninlymphoma.bsky.social · 16/11/2024
🌏 Please join our free educational #CareerDevelopment webinar next Wed Nov 20 with Laurence Hollobon + panel of emerging global women in lymphoma⚕️ 👉Please register us06web.zoom.us/webinar/regi... With thanks to Gilead Sciences, IFLI, Eli Lilly & Co, Lymphoma Australia
084